The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Burns Treatment-Global Market Insights and Sales Trends 2025
Synopsis
The global Burns Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Burns Treatment in various end use industries. The expanding demands from the In-patient and Out-patient, are propelling Burns Treatment market. ENERGIF-711, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the AG-110 segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Burns Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Burns Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Burns Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Burns Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Burns Treatment covered in this report include Adocia, AlgiPharma AS, Amarantus Bioscience Holdings, Inc., American Gene Technologies International Inc., Biogenomics Limited, CytoTools AG, Destiny Pharma Limited, Lakewood-Amedex Inc and Madam Therapeutics B.V., etc.
The global Burns Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Adocia
AlgiPharma AS
Amarantus Bioscience Holdings, Inc.
American Gene Technologies International Inc.
Biogenomics Limited
CytoTools AG
Destiny Pharma Limited
Lakewood-Amedex Inc
Madam Therapeutics B.V.
MediWound Ltd.
Mitochon Pharmaceuticals, Inc.
Phosphagenics Limited
Se-cure Pharmaceuticals Ltd.
Sinclair Pharma Plc
Stratatech Corporation
Tissue Therapies Limited
USV Pvt Ltd
Global Burns Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Burns Treatment market, Segment by Type:
ENERGIF-711
AG-110
NJ-01SS
P-148
Others
Global Burns Treatment market, by Application
In-patient
Out-patient
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Burns Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Burns Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Burns Treatment in various end use industries. The expanding demands from the In-patient and Out-patient, are propelling Burns Treatment market. ENERGIF-711, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the AG-110 segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Burns Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Burns Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Burns Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Burns Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Burns Treatment covered in this report include Adocia, AlgiPharma AS, Amarantus Bioscience Holdings, Inc., American Gene Technologies International Inc., Biogenomics Limited, CytoTools AG, Destiny Pharma Limited, Lakewood-Amedex Inc and Madam Therapeutics B.V., etc.
The global Burns Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Adocia
AlgiPharma AS
Amarantus Bioscience Holdings, Inc.
American Gene Technologies International Inc.
Biogenomics Limited
CytoTools AG
Destiny Pharma Limited
Lakewood-Amedex Inc
Madam Therapeutics B.V.
MediWound Ltd.
Mitochon Pharmaceuticals, Inc.
Phosphagenics Limited
Se-cure Pharmaceuticals Ltd.
Sinclair Pharma Plc
Stratatech Corporation
Tissue Therapies Limited
USV Pvt Ltd
Global Burns Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Burns Treatment market, Segment by Type:
ENERGIF-711
AG-110
NJ-01SS
P-148
Others
Global Burns Treatment market, by Application
In-patient
Out-patient
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Burns Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Burns Treatment
1.1 Burns Treatment Market Overview
1.1.1 Burns Treatment Product Scope
1.1.2 Burns Treatment Market Status and Outlook
1.2 Global Burns Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Burns Treatment Market Size by Region (2018-2029)
1.4 Global Burns Treatment Historic Market Size by Region (2018-2023)
1.5 Global Burns Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Burns Treatment Market Size (2018-2029)
1.6.1 North America Burns Treatment Market Size (2018-2029)
1.6.2 Europe Burns Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Burns Treatment Market Size (2018-2029)
1.6.4 Latin America Burns Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Burns Treatment Market Size (2018-2029)
2 Burns Treatment Market by Type
2.1 Introduction
2.1.1 ENERGIF-711
2.1.2 AG-110
2.1.3 NJ-01SS
2.1.4 P-148
2.1.5 Others
2.2 Global Burns Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Burns Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Burns Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Burns Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Burns Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Burns Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Burns Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Burns Treatment Revenue Breakdown by Type (2018-2029)
3 Burns Treatment Market Overview by Application
3.1 Introduction
3.1.1 In-patient
3.1.2 Out-patient
3.2 Global Burns Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Burns Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Burns Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Burns Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Burns Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Burns Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Burns Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Burns Treatment Revenue Breakdown by Application (2018-2029)
4 Burns Treatment Competition Analysis by Players
4.1 Global Burns Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Burns Treatment as of 2022)
4.3 Date of Key Players Enter into Burns Treatment Market
4.4 Global Top Players Burns Treatment Headquarters and Area Served
4.5 Key Players Burns Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Burns Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Adocia
5.1.1 Adocia Profile
5.1.2 Adocia Main Business
5.1.3 Adocia Burns Treatment Products, Services and Solutions
5.1.4 Adocia Burns Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Adocia Recent Developments
5.2 AlgiPharma AS
5.2.1 AlgiPharma AS Profile
5.2.2 AlgiPharma AS Main Business
5.2.3 AlgiPharma AS Burns Treatment Products, Services and Solutions
5.2.4 AlgiPharma AS Burns Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 AlgiPharma AS Recent Developments
5.3 Amarantus Bioscience Holdings, Inc.
5.3.1 Amarantus Bioscience Holdings, Inc. Profile
5.3.2 Amarantus Bioscience Holdings, Inc. Main Business
5.3.3 Amarantus Bioscience Holdings, Inc. Burns Treatment Products, Services and Solutions
5.3.4 Amarantus Bioscience Holdings, Inc. Burns Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 American Gene Technologies International Inc. Recent Developments
5.4 American Gene Technologies International Inc.
5.4.1 American Gene Technologies International Inc. Profile
5.4.2 American Gene Technologies International Inc. Main Business
5.4.3 American Gene Technologies International Inc. Burns Treatment Products, Services and Solutions
5.4.4 American Gene Technologies International Inc. Burns Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 American Gene Technologies International Inc. Recent Developments
5.5 Biogenomics Limited
5.5.1 Biogenomics Limited Profile
5.5.2 Biogenomics Limited Main Business
5.5.3 Biogenomics Limited Burns Treatment Products, Services and Solutions
5.5.4 Biogenomics Limited Burns Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Biogenomics Limited Recent Developments
5.6 CytoTools AG
5.6.1 CytoTools AG Profile
5.6.2 CytoTools AG Main Business
5.6.3 CytoTools AG Burns Treatment Products, Services and Solutions
5.6.4 CytoTools AG Burns Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 CytoTools AG Recent Developments
5.7 Destiny Pharma Limited
5.7.1 Destiny Pharma Limited Profile
5.7.2 Destiny Pharma Limited Main Business
5.7.3 Destiny Pharma Limited Burns Treatment Products, Services and Solutions
5.7.4 Destiny Pharma Limited Burns Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Destiny Pharma Limited Recent Developments
5.8 Lakewood-Amedex Inc
5.8.1 Lakewood-Amedex Inc Profile
5.8.2 Lakewood-Amedex Inc Main Business
5.8.3 Lakewood-Amedex Inc Burns Treatment Products, Services and Solutions
5.8.4 Lakewood-Amedex Inc Burns Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Lakewood-Amedex Inc Recent Developments
5.9 Madam Therapeutics B.V.
5.9.1 Madam Therapeutics B.V. Profile
5.9.2 Madam Therapeutics B.V. Main Business
5.9.3 Madam Therapeutics B.V. Burns Treatment Products, Services and Solutions
5.9.4 Madam Therapeutics B.V. Burns Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Madam Therapeutics B.V. Recent Developments
5.10 MediWound Ltd.
5.10.1 MediWound Ltd. Profile
5.10.2 MediWound Ltd. Main Business
5.10.3 MediWound Ltd. Burns Treatment Products, Services and Solutions
5.10.4 MediWound Ltd. Burns Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 MediWound Ltd. Recent Developments
5.11 Mitochon Pharmaceuticals, Inc.
5.11.1 Mitochon Pharmaceuticals, Inc. Profile
5.11.2 Mitochon Pharmaceuticals, Inc. Main Business
5.11.3 Mitochon Pharmaceuticals, Inc. Burns Treatment Products, Services and Solutions
5.11.4 Mitochon Pharmaceuticals, Inc. Burns Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Mitochon Pharmaceuticals, Inc. Recent Developments
5.12 Phosphagenics Limited
5.12.1 Phosphagenics Limited Profile
5.12.2 Phosphagenics Limited Main Business
5.12.3 Phosphagenics Limited Burns Treatment Products, Services and Solutions
5.12.4 Phosphagenics Limited Burns Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Phosphagenics Limited Recent Developments
5.13 Se-cure Pharmaceuticals Ltd.
5.13.1 Se-cure Pharmaceuticals Ltd. Profile
5.13.2 Se-cure Pharmaceuticals Ltd. Main Business
5.13.3 Se-cure Pharmaceuticals Ltd. Burns Treatment Products, Services and Solutions
5.13.4 Se-cure Pharmaceuticals Ltd. Burns Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Se-cure Pharmaceuticals Ltd. Recent Developments
5.14 Sinclair Pharma Plc
5.14.1 Sinclair Pharma Plc Profile
5.14.2 Sinclair Pharma Plc Main Business
5.14.3 Sinclair Pharma Plc Burns Treatment Products, Services and Solutions
5.14.4 Sinclair Pharma Plc Burns Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Sinclair Pharma Plc Recent Developments
5.15 Stratatech Corporation
5.15.1 Stratatech Corporation Profile
5.15.2 Stratatech Corporation Main Business
5.15.3 Stratatech Corporation Burns Treatment Products, Services and Solutions
5.15.4 Stratatech Corporation Burns Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Stratatech Corporation Recent Developments
5.16 Tissue Therapies Limited
5.16.1 Tissue Therapies Limited Profile
5.16.2 Tissue Therapies Limited Main Business
5.16.3 Tissue Therapies Limited Burns Treatment Products, Services and Solutions
5.16.4 Tissue Therapies Limited Burns Treatment Revenue (US$ Million) & (2018-2023)
5.16.5 Tissue Therapies Limited Recent Developments
5.17 USV Pvt Ltd
5.17.1 USV Pvt Ltd Profile
5.17.2 USV Pvt Ltd Main Business
5.17.3 USV Pvt Ltd Burns Treatment Products, Services and Solutions
5.17.4 USV Pvt Ltd Burns Treatment Revenue (US$ Million) & (2018-2023)
5.17.5 USV Pvt Ltd Recent Developments
6 North America
6.1 North America Burns Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Burns Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Burns Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Burns Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Burns Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Burns Treatment Market Dynamics
11.1 Burns Treatment Industry Trends
11.2 Burns Treatment Market Drivers
11.3 Burns Treatment Market Challenges
11.4 Burns Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
